Authors:
HORNAK J
OXBURY S
OXBURY J
IVERSEN SD
GAFFAN D
Citation: J. Hornak et al., HEMIFIELD-SPECIFIC VISUAL RECOGNITION MEMORY IMPAIRMENTS IN PATIENTS WITH UNILATERAL TEMPORAL-LOBE REMOVALS, Neuropsychologia, 35(9), 1997, pp. 1311-1315
Authors:
CALVERT GA
NORMAN WD
GEDDES J
IVERSEN SD
CROW TJ
Citation: Ga. Calvert et al., EVIDENCE THAT MANUAL DOMINANCE AND LATERALIZATION OF A LETTER-MATCHING TASK ARE DECOUPLED IN SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, p.
Citation: G. Calvert et al., A TEST OF BIMANUAL COORDINATION - EVIDENCE FOR INTACT KINESTHETIC SELF-MONITORING IN SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, p.
Authors:
DAWSON GR
RUPNIAK NMJ
IVERSEN SD
CURNOW R
TYE S
STANHOPE KJ
TRICKLEBANK MD
Citation: Gr. Dawson et al., LACK OF EFFECT OF CCKB RECEPTOR ANTAGONISTS IN ETHOLOGICAL AND CONDITIONED ANIMAL SCREENS FOR ANXIOLYTIC DRUGS, Psychopharmacology, 121(1), 1995, pp. 109-117
Authors:
DAWSON GR
CRAWFORD SP
COLLINSON N
IVERSEN SD
TRICKLEBANK MD
Citation: Gr. Dawson et al., EVIDENCE THAT THE ANXIOLYTIC-LIKE EFFECTS OF CHLORDIAZEPOXIDE ON THE ELEVATED PLUS-MAZE ARE CONFOUNDED BY INCREASES IN LOCOMOTOR-ACTIVITY, Psychopharmacology, 118(3), 1995, pp. 316-323
Citation: Sd. Iversen, INTERACTIONS BETWEEN EXCITATORY AMINO-ACIDS AND DOPAMINE SYSTEMS IN THE FOREBRAIN - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE, Behavioural pharmacology, 6(5-6), 1995, pp. 478-491
Citation: Sd. Iversen, INTERACTIONS BETWEEN EXCITATORY AMINO-ACIDS AND DOPAMINE SYSTEMS IN THE BASAL GANGLIA - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE, Behavioural pharmacology, 6(5-6), 1995, pp. 621-622
Citation: Gr. Dawson et al., A COMPARISON OF THE EFFECTS OF THE NOVEL MUSCARINIC RECEPTOR AGONISTSL-689,660 AND AF102B IN TESTS OF REFERENCE AND WORKING-MEMORY, Psychopharmacology, 113(3-4), 1994, pp. 361-368
Citation: Gr. Dawson et al., ONE-TRIAL TOLERANCE TO THE EFFECTS OF CHLORDIAZEPOXIDE ON THE ELEVATED PLUS-MAZE MAY BE DUE TO LOCOMOTOR HABITUATION, NOT REPEATED DRUG EXPOSURE, Psychopharmacology, 113(3-4), 1994, pp. 570-572
Authors:
SIRINATHSINGHJI DJS
SCHULIGOI R
HEAVENS RP
DIXON A
IVERSEN SD
HILL RG
Citation: Djs. Sirinathsinghji et al., TEMPORAL CHANGES IN THE MESSENGER-RNA LEVELS OF CELLULAR IMMEDIATE-EARLY GENES AND NEUROTRANSMITTER RECEPTOR GENES IN THE RAT NEOSTRIATUM AND SUBSTANTIA-NIGRA AFTER ACUTE TREATMENT WITH ETICLOPRIDE, A DOPAMINED-2 RECEPTOR ANTAGONIST/, Neuroscience, 62(2), 1994, pp. 407-423
Authors:
PATEL S
SMITH AJ
CHAPMAN KL
FLETCHER AE
KEMP JA
MARSHALL GR
HARGREAVES RJ
RYECROFT W
IVERSEN LL
IVERSEN SD
BAKER R
SHOWELL GA
BOURRAIN S
NEDUVELIL JG
MATASSA VG
FREEDMAN SB
Citation: S. Patel et al., BIOLOGICAL PROPERTIES OF THE BENZODIAZEPINE AMIDINE DERIVATIVE L-740,093, A CHOLECYSTOKININ-B GASTRIN RECEPTOR ANTAGONIST WITH HIGH-AFFINITY IN-VITRO AND HIGH POTENCY IN-VIVO, Molecular pharmacology, 46(5), 1994, pp. 943-948
Citation: Gr. Dawson et Sd. Iversen, THE EFFECTS OF NOVEL CHOLINESTERASE-INHIBITORS AND SELECTIVE MUSCARINIC RECEPTOR AGONISTS IN TESTS OF REFERENCE AND WORKING-MEMORY, Behavioural brain research, 57(2), 1993, pp. 143-153
Authors:
RUPNIAK NMJ
SCHAFFER L
SIEGL P
IVERSEN SD
Citation: Nmj. Rupniak et al., FAILURE OF INTRAVENOUS PENTAGASTRIN CHALLENGE TO INDUCE PANIC-LIKE EFFECTS IN RHESUS-MONKEYS, Neuropeptides, 25(2), 1993, pp. 115-119
Citation: Nmj. Rupniak et Sd. Iversen, COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA - HOW EXPERIMENTAL-MODELS USINGNONHUMAN-PRIMATES MAY ASSIST IMPROVED DRUG-THERAPY FOR NEGATIVE SYMPTOMS, Neuropsychologia, 31(10), 1993, pp. 1133-1146
Citation: Sd. Iversen, NMDA DOPAMINE INTERACTIONS - A NOVEL TARGET FOR ANTIPSYCHOTIC-DRUGS, Journal of neurochemistry, 61, 1993, pp. 190000240-190000240
Authors:
RUPNIAK NMJ
BOYCE S
WILLIAMS AR
COOK G
LONGMORE J
SEABROOK GR
CAESER M
IVERSEN SD
HILL RG
Citation: Nmj. Rupniak et al., ANTINOCICEPTIVE ACTIVITY OF NK(1) RECEPTOR ANTAGONISTS - NONSPECIFIC EFFECTS OF RACEMIC RP67580, British Journal of Pharmacology, 110(4), 1993, pp. 1607-1613